Subscribe To
GDTC / Why Is CytoMed Therapeutics (GDTC) Stock Up 157% Today?
GDTC News
By Seeking Alpha
September 1, 2023
CytoMed Therapeutics: An Innovative Immunology Biotech Company To Watch
CytoMed Therapeutics is developing next-generation CAR-T cell therapies from γδ T cells for multiple solid tumor indications. The use of γδ T cell more_horizontal
By InvestorPlace
July 11, 2023
Why Is CytoMed Therapeutics (GDTC) Stock Up 157% Today?
CytoMed Therapeutics (NASDAQ: GDTC ) stock is rocketing higher on Tuesday despite a lack of news concerning the company this morning. Instead of a pre more_horizontal